Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
How difficult it is to change dietary behaviour experience of older people with sarcopenic obesity: a qualitative study
For people who stop using GLP-1 weight-loss drugs such as Ozempic, gaining the weight back might be the least of their concerns
Some bills have stalled while others remain alive, including a proposal in Arkansas requiring GLP-1s to be covered under Medicaid when prescribed specifically for weight loss
Furthermore, it provides an overview of the anti-obesity and anti-diabetic effects mediated by the enhanced endogenous secretion of GLP-1 and their underlying mechanisms
US$ 26.45
US$ 22.53
US$ 28.96
